Drugs Made In America Acquisition
0
2
+$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Profitable0Revenue
5.94MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Drugs Made In America Acquisition Corp. (DMAAR) is a special purpose acquisition company (SPAC), established with the primary objective of identifying and acquiring one or more active businesses or their assets. The company plans to achieve these acquisitions through various transactional structures, including mergers, exchanges of equity shares, direct asset purchases, stock acquisitions, or broader corporate reorganizations.
Show More
CEO
ISIN
KYG2847J1123
Listings
0 Comments
Share your thoughts
FAQs
What is Drugs Made In America Acquisition stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Drugs Made In America Acquisition stocks are traded under the ticker DMAAR.BOATS.
What is Drugs Made In America Acquisition revenue for the last year?▼
Drugs Made In America Acquisition revenue for the last year amounts to 0 USD.
What is Drugs Made In America Acquisition net income for the last year?▼
DMAAR.BOATS net income for the last year is 5.94M USD.
In which sector is Drugs Made In America Acquisition located?▼
Drugs Made In America Acquisition operates in the Other sector.
When did Drugs Made In America Acquisition complete a stock split?▼
Drugs Made In America Acquisition has not had any recent stock splits.